GLP-1 and GIP tend to lower glucose, while glucagon can raise it
GLP-1 also acts on receptors in your brain to reduce hunger cues, which can lower appetite and overall calorie intake
Meanwhile, Hanmi Pharmaceuticals is advancing its triple agonist efocipegtrutide
When to call your provider Within 3-5 days: No bowel movement for 5+ days despite using Miralax or other osmotic laxative Severe abdominal pain or distension Inability to pass gas Vomiting, especially if it tastes or smells fecal Within 1-2 weeks: Constipation not improving after 2 weeks of consistent dietary changes plus Miralax Blood in stool (bright red or dark/tarry) Severe pain during bowel movements Unintended weight loss beyond expected from the medication At your next scheduled visit: Mild persistent constipation that's manageable but bothersome Questions about whether to escalate dose given current constipation Interest in prescription motility agents The threshold for calling is lower if you have a history of bowel obstruction, diverticulitis, inflammatory bowel disease, or prior abdominal surgery

All-in-one research-ready package 99% HPLC purity Retatrutide Safe, sterile, and easy preparation Free sterile syringe included for precision DISCLAIMER - For in-vitro Research Use Only